メニュー

アメリカCDCの発表について

[2014.10.05]

アメリカの疾病対策センター(CDC)の今年のインフルエンザ対策が発表されています。2才から8才の健康なヒトはフルミストのほうが推奨されています。原文を転記しておきます。LAIVはフルミスト、IIVは注射型ワクチンです。

For 2014–15, ACIP recommends the following:

  1. All persons aged ≥6 months should receive influenza vaccine annually. Influenza vaccination should not be delayed to procure a specific vaccine preparation if an appropriate one is already available.
  2. When immediately available, LAIV should be used for healthy children aged 2 through 8 years who have no contraindications or precautions (Category A). If LAIV is not immediately available, IIV should be used. Vaccination should not be delayed to procure LAIV. The age of 8 years is selected as the upper age limit for this recommendation based on demonstration of superior efficacy of LAIV (ages 2 to 6 years), and for programmatic consistency (8 years is the upper age limit for receipt of 2 doses of influenza vaccine in a previously unvaccinated child). This recommendation should be implemented for the 2014–15 season as feasible, but not later than the 2015–16 season.

HOME

▲ ページのトップに戻る

Close

HOME